Sofosbuvir: A Potential Treatment for Ebola

被引：1
|
作者：
Reznik, Sandra E. [1 ,2 ,3 ,4 ]
Tiwari, Amit K. [5 ]
Ashby, Charles R., Jr. [1 ]
机构：
[1] St Johns Univ, Dept Pharmaceut Sci, Coll Pharm & Hlth Sci, Queens, NY 11439 USA
[2] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA
[3] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Obstet & Gynecol, Bronx, NY 10467 USA
[4] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Womens Hlth, Bronx, NY 10467 USA
[5] Univ Toledo, Dept Pharmacol & Expt Therapeut, Coll Pharm & Pharmaceut Sci, 2801 W Bancroft St, Toledo, OH 43606 USA
来源：
FRONTIERS IN PHARMACOLOGY | 2018年 / 9卷
关键词：
Ebola; sofosbuvir; RNA virus; RNA dependent RNA polymerase; triphosphate metabolite; HEPATITIS-C VIRUS; DISEASE; INFECTION; RNA; FAVIPIRAVIR; POLYMERASE; ANTIVIRALS; GS-5734; PATIENT;
D O I：
10.3389/fphar.2018.01139
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Tolerance and Persistence of Ebola Virus in Primary Cells from Mops condylurus, a Potential Ebola Virus Reservoir
    Bokelmann, Marcel
    Vogel, Uwe
    Debeljak, Franka
    Duex, Ariane
    Riesle-Sbarbaro, Silke
    Lander, Angelika
    Wahlbrink, Annette
    Kromarek, Nicole
    Neil, Stuart
    Couacy-Hymann, Emmanuel
    Prescott, Joseph
    Kurth, Andreas
    VIRUSES-BASEL, 2021, 13 (11):
  • [22] Effectiveness of Sofosbuvir and Daclatasvir in treatment of Hepatitis-C: An experience of tertiary care hospital in Karachi
    Butt, Nazish
    Anoshia
    Khan, Muhammad Ali
    Akbar, Ali
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (07) : 2014 - 2019
  • [23] The safety and efficacy of ledipasvir/sofosbuvir for the treatment of a nosocomial outbreak of HCV in patients with significant cardiovascular disease
    Simon, Tracey G.
    Kim, Arthur Y.
    Stamm, Luisa M.
    Liu, Lin
    Mo, Hongmei
    Doehle, Brian
    Pang, Phillip S.
    Brainard, Diana M.
    McHutchison, John G.
    Gustafson, Jenna
    Lauer, Georg M.
    Chung, Raymond T.
    ANTIVIRAL THERAPY, 2016, 21 (03) : 185 - 194
  • [24] Community-based real-world treatment outcomes of sofosbuvir/ledipasvir in Asians with chronic hepatitis C virus genotype 6 in the United States
    Wong, R. J.
    Nguyen, M. T.
    Trinh, H. N.
    Huynh, A.
    Ly, M. T.
    Nguyen, H. A.
    Nguyen, K. K.
    Yang, J.
    Garcia, R. T.
    Levitt, B.
    da Silveira, E.
    Gish, R. G.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (01) : 17 - 21
  • [25] Against the clock towards new Ebola virus therapies
    Martinez-Romero, Caries
    Garcia-Sastre, Adolfo
    VIRUS RESEARCH, 2015, 209 : 4 - 10
  • [26] Antiviral therapeutics for the treatment of Ebola virus infection
    Cardile, Anthony P.
    Downey, Lydia G.
    Wiseman, Perry D.
    Warren, Travis K.
    Bavari, Sina
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 138 - 143
  • [27] Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors
    Dashti-Khavidaki, Simin
    Khalili, Hossein
    Nasiri-Toosi, Mohsen
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (05) : 525 - 529
  • [28] Multicenter Experience using Ledipasvir/Sofosbuvir ± RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment
    Aqel, Bashar
    Leise, Michael
    Vargas, Hugo E.
    Watt, Kymberly D.
    Keaveny, Andrew P.
    Zhang, Nan
    Pungpapong, Surakit
    ANNALS OF HEPATOLOGY, 2018, 17 (05) : 815 - 821
  • [29] Benign course of residual inflammation at end of treatment of liver transplant recipients after sofosbuvir based therapy
    Ismail, Bahaaeldeen
    Benrajab, Karim M.
    Bejarano, Pablo
    Ruiz, Phillip
    Sears, Debbie
    Tzakis, Andreas
    Zervos, Xaralambos Bobby
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (03) : 602 - 611
  • [30] Effectiveness of ledipasvir/sofosbuvir in real-world patients with chronic hepatitis C: a collaborative treatment approach
    Johnson, Steven W.
    Ammirati, Shelby R.
    Hartis, Charles E.
    Weber, Stephen F.
    Morgan, Michael R.
    Darnell, Timothy A.
    Silwal, Adwait
    Schmidlin, Holly N.
    Priest, David H.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (06) : 778 - 781
12345